Search Results - "AGARWAL, Roshan"
-
1
Ovarian cancer: strategies for overcoming resistance to chemotherapy
Published in Nature reviews. Cancer (01-07-2003)“…Ovarian cancer is responsible for 4% of deaths from cancer in women. Treatment comprises a combination of surgery and chemotherapy, but patients typically…”
Get full text
Journal Article -
2
EMA/CO for High-Risk Gestational Trophoblastic Neoplasia: Good Outcomes With Induction Low-Dose Etoposide-Cisplatin and Genetic Analysis
Published in Journal of clinical oncology (10-01-2013)“…Patients with high-risk (International Federation of Gynecology and Obstetrics score ≥ 7) gestational trophoblastic neoplasia (GTN) frequently receive…”
Get full text
Journal Article -
3
Mechanisms of transcoelomic metastasis in ovarian cancer
Published in The lancet oncology (01-11-2006)“…Metastasis from epithelial ovarian cancer can occur via the transcoelomic, haematogeneous, or lymphatic route. Of these, transcoelomic metastasis is the most…”
Get more information
Journal Article -
4
Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
Published in Cancer research (Chicago, Ill.) (15-05-2009)“…Metaplastic breast cancers (MBC) are aggressive, chemoresistant tumors characterized by lineage plasticity. To advance understanding of their pathogenesis and…”
Get full text
Journal Article -
5
Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT
Published in Health technology assessment (Winchester, England) (01-07-2021)“…Venous access devices are used for patients receiving long-term chemotherapy. These include centrally inserted tunnelled catheters or Hickman-type devices…”
Get full text
Journal Article -
6
DNA-PK Mediates AKT Activation and Apoptosis Inhibition in Clinically Acquired Platinum Resistance
Published in Neoplasia (New York, N.Y.) (01-11-2011)“…Abstract Clinical resistance to chemotherapy is a frequent event in cancer treatment and is closely linked to poor outcome. High-grade serous (HGS) ovarian…”
Get full text
Journal Article -
7
Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study
Published in The Lancet (British edition) (2012)“…Summary Background Indications for chemotherapy in gestational trophoblastic disease include raised human chorionic gonadotropin (hCG) concentrations 6 months…”
Get full text
Journal Article -
8
Androgen Receptor Levels and Association with PIK3CA Mutations and Prognosis in Breast Cancer
Published in Clinical cancer research (01-04-2009)“…Purpose: To examine the androgen receptor (AR) levels in breast cancer and to assess the impact of AR expression on patient outcomes. Experimental Design:…”
Get full text
Journal Article -
9
Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study
Published in The Lancet (British edition) (04-07-2009)“…Summary Background Placental-site trophoblastic tumours are a rare form of gestational trophoblastic disease and consequently information about optimum…”
Get full text
Journal Article -
10
Emerging Role of the RAB25 Small GTPase in Cancer
Published in Traffic (Copenhagen, Denmark) (01-11-2009)“…RAB25, a member of the rat sarcoma (RAS) family of small GTPase, has been implicated in the pathophysiology of ovarian, breast and other cancers. Its role in…”
Get full text
Journal Article -
11
Central Giant Cell Granuloma of the Mandible: A Case Report
Published in Curēus (Palo Alto, CA) (06-04-2024)“…This article presents a clinical case of a central giant cell granuloma (CGCG) resembling a periapical lesion of endodontic origin. A 39-year-old, otherwise…”
Get full text
Journal Article -
12
Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer
Published in Clinical cancer research (01-06-2009)“…Purpose: We studied the expression levels of cyclins B1, D1, and E1 and the implications of cyclin overexpression for patient outcomes in distinct breast…”
Get full text
Journal Article -
13
Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers
Published in Clinical proteomics (01-12-2010)“…Introduction The lack of large panels of validated antibodies, tissue handling variability, and intratumoral heterogeneity potentially hamper comprehensive…”
Get full text
Journal Article -
14
Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells
Published in Cellular signalling (01-06-2010)“…Drug resistance remains a barrier to the effective long term treatment of ovarian cancer. We have established an RNAi-based screen to identify genes which…”
Get full text
Journal Article -
15
Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set
Published in Molecular cancer therapeutics (01-02-2010)“…Aberrations in oncogenes and tumor suppressors frequently affect the activity of critical signal transduction pathways. To analyze systematically the…”
Get full text
Journal Article -
16
Malignant Ovarian Germ Cell Tumors: Identification of Novel Prognostic Markers and Long-Term Outcome After Multimodality Treatment
Published in Journal of clinical oncology (20-10-2006)“…Malignant ovarian germ cell tumors are rare and knowledge about prognostic parameters currently is limited. This study was undertaken to evaluate long-term…”
Get full text
Journal Article -
17
The OPCML tumor suppressor functions as a cell surface repressor-adaptor, negatively regulating receptor tyrosine kinases in epithelial ovarian cancer
Published in Cancer discovery (01-02-2012)“…Epithelial ovarian cancer is the leading cause of death from gynecologic malignancy, and its molecular basis is poorly understood. We previously demonstrated…”
Get more information
Journal Article -
18
Eligibility of patients with brain metastases for phase I trials: time for a rethink?
Published in The lancet oncology (01-10-2008)“…Summary Since the inception of phase I clinical trials in cancer, patients with symptomatic brain metastases have commonly been excluded from participation…”
Get full text
Journal Article -
19
Transient ectopic expression as a method to detect genes conferring drug resistance
Published in International journal of cancer (01-06-2008)“…Ectopic expression provides an alternative to RNAi to conduct functional genomic screens. We have determined whether transient expression can be used to…”
Get full text
Journal Article -
20
An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients
Published in Ecancermedicalscience (05-01-2016)“…The Association of Cancer Physicians in the United Kingdom has developed a strategy to improve outcomes for cancer patients and identified the goals and…”
Get full text
Journal Article